Boceprevir

Assistant Editor-In-Chief: Nina Axiotakis [mailto:naxiotak@oberlin.edu]

Boceprevir (INN) is a protease inhibitor being studied as a treatment for hepatitis C.

It is being developed by Schering-Plough. As of 2008, it is in phase II clinical trials.